Evidence map›Paper›PMID 26507767›Full record

ArticleScientific reports2015

The commensal infant gut meta-mobilome as a potential reservoir for persistent multidrug resistance integrons.

Anuradha Ravi, Ekaterina Avershina, Steven L Foley, Jane Ludvigsen, Ola Storrø, Torbjørn Øien, Roar Johnsen, Anne L McCartney, Trine M L'Abée-Lund, Knut Rudi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Grand Challenges in Understanding Gut Microbes.Frontiers in microbiology · 2021
    Article
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Microbiome as a tool and a target in the effort to address antimicrobial resistance.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Early microbiota, antibiotics and health.Cellular and molecular life sciences : CMLS · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Anuradha RaviNorwegian University of Life Sciences, Chemistry, Biotechnology and Food science department (IKBM), Campus Ås, Ås 1432, Norway.
Ekaterina AvershinaNorwegian University of Life Sciences, Chemistry, Biotechnology and Food science department (IKBM), Campus Ås, Ås 1432, Norway.
Steven L FoleyNational Center for Toxicological Research, U.S. Food and Drug Administration, Division of Microbiology, Jefferson, AR 72079.
Jane LudvigsenNorwegian University of Life Sciences, Chemistry, Biotechnology and Food science department (IKBM), Campus Ås, Ås 1432, Norway.
Ola StorrøDepartment of Public Health and General Practice, Norwegian University of Science and Technology, 9491 Trondheim, Norway.
Torbjørn ØienDepartment of Public Health and General Practice, Norwegian University of Science and Technology, 9491 Trondheim, Norway.
Roar JohnsenDepartment of Public Health and General Practice, Norwegian University of Science and Technology, 9491 Trondheim, Norway.
Anne L McCartneyMicrobial Ecology &Health Group, Department of Food and Nutritional Sciences, University of Reading, Reading, UK.
Trine M L'Abée-LundNorwegian University of Life Sciences, Department of Food safety and Infection Biology, Campus Adamstuen, Oslo 0454, Norway.
Knut RudiNorwegian University of Life Sciences, Chemistry, Biotechnology and Food science department (IKBM), Campus Ås, Ås 1432, Norway.
Norwegian University of Life Sciences · NONorwegian University of Science and Technology · NOUnited States Food and Drug Administration · USUniversity of Reading · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the accumulating knowledge on the development and establishment of the gut microbiota, its role as a reservoir for multidrug resistance is not well understood. This study investigated the prevalence and persistence patterns of an integrase gene (int1), used as a proxy for integrons (which often carry multiple antimicrobial resistance genes), in the fecal microbiota of 147 mothers and their children sampled longitudinally from birth to 2 years. The study showed the int1 gene was detected in 15% of the study population, and apparently more persistent than the microbial community structure itself. We found int1 to be persistent throughout the first two years of life, as well as between mothers and their 2-year-old children. Metagenome sequencing revealed integrons in the gut meta-mobilome that were associated with plasmids and multidrug resistance. In conclusion, the persistent nature of integrons in the infant gut microbiota makes it a potential reservoir of mobile multidrug resistance.

Indexed as

IntegronsSymbiosisBacteriaBacterial Physiological PhenomenaDNA, BacterialDrug Resistance, Multiple, BacterialFemaleGastrointestinal TractHumansInfantInfant, NewbornIntegrasesPregnancyDNA, BacterialIntegrases

Identifiers

PMID26507767
PMCPMC4623605
OpenAlexW2194744065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.